ASTRAZEN - Astrazeneca Pharma India

Astrazeneca Pharma India

ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in

Stock Price vs Company Growth

3.2%

7.1%

12.4%

8.3%

11.3%

35.2%

19.3%

10y

22.4%

all

14.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 6,289 3.2%

6,222

8,140

Company Overview

Sales

1,485 Cr

Growth: 26.0%

Profit after Tax

81.9 Cr

Growth: 3.1%

Mid Cap

15,722 Cr

P/E: 192.0x

Industry P/E: 35.6x

Fundamentals

Sales (Cr)	₹ 1,485
Growth	26.0%
EBITDA	10.4%
P/S	10.6x
Dividend	0.4%
P/E	192.0x
Book Value	₹ 295
PEG Ratio	7.4x
ROE	11.5%
P/B	21.3x

Shareholding Pattern

Institutions

Promoters

Astrazeneca Pharmaceuticals Ab

75.0 %

Others

Tejas Bhalchandra Trivedi

2.67 %

Shivani T. Trivedi

1.98 %

Minaxi Bhalchandra Trivedi

1.84 %

Iepf

0.46 %

Increase Decrease No change

Company Profile Detailed

The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory.Core Therapy AreasCardiovascularOncologyRespiratoryMilestones and achievements1979: Astra IDL formation.1982: Astra factory foundation.1992: Launch of Cerviprime, Plendil, Ramace, Rhinocort and Imdur.

Belongs to (16 Indices) view more

Investors (43)

shivani....

merrill....

morgan.s...

Followers (3)

nitin2

keerthi

deepak